Edition:
United States

Haemonetics Corp (HAE.N)

HAE.N on New York Stock Exchange

43.03USD
22 Sep 2017
Change (% chg)

$1.01 (+2.40%)
Prev Close
$42.02
Open
$42.04
Day's High
$43.06
Day's Low
$42.04
Volume
75,769
Avg. Vol
93,155
52-wk High
$43.75
52-wk Low
$32.78

Chart for

About

Haemonetics Corporation (Haemonetics) is a healthcare company. The Company provides various products to customers involved in the processing, handling and analysis of blood. The Company's segments include Japan, EMEA, North America Plasma and All Other. Haemonetics provides plasma collection systems and software, which enable... (more)

Overall

Beta: 0.86
Market Cap(Mil.): $2,263.65
Shares Outstanding(Mil.): 52.61
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 31.44 16.08
EPS (TTM): -- -- --
ROI: -- 13.78 14.60
ROE: -- 16.62 14.03

BRIEF-Haemonetics appoints David Wilson plasma business unit president

* Haemonetics appoints David Wilson plasma business unit president Source text for Eikon: Further company coverage:

Sep 14 2017

BRIEF-Haemonetics Corp reports Q1 earnings per share $0.38

* Qtrly earnings per share $0.38; Qtrly adjusted earnings per share $0.33

Aug 07 2017

BRIEF-Haemonetics announces FDA clearance of new plasmapheresis system branded nexsys PCS

* Haemonetics announces FDA clearance of new plasmapheresis system branded Nexsys pcs Source text for Eikon: Further company coverage:

Jul 28 2017

BRIEF-Haemonetics Corp reports qtrly loss per share $0.98

* Haemonetics Corp- fourth quarter fiscal 2017 revenue of $228.1 million, down 6pct compared to the fourth quarter of fiscal 2016

May 08 2017

Competitors

Earnings vs. Estimates